Jeffrey L Browning

Author PubWeight™ 34.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science 2014 5.47
2 BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2002 2.94
3 A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell 2009 2.64
4 Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell 2012 2.50
5 TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron 2005 2.39
6 Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans. Blood 2011 2.33
7 Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat Rev Immunol 2003 2.10
8 Lymphotoxin β receptor signaling promotes development of autoimmune pancreatitis. Gastroenterology 2012 1.43
9 Regulation of T(H)2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells. Nat Immunol 2012 1.40
10 Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. J Clin Invest 2011 1.22
11 A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis. J Immunol 2003 1.09
12 Pillars article: A lymphotoxin-B-specific receptor. Science. 1994. 264: 707-710. J Immunol 2014 1.06
13 Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice. Arthritis Res Ther 2009 1.04
14 TRAF3 controls activation of the canonical and alternative NFkappaB by the lymphotoxin beta receptor. J Biol Chem 2010 1.03
15 Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy. Cancer Res 2006 1.01
16 A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT. J Clin Invest 2003 0.99
17 Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway. J Clin Invest 2002 0.97
18 Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome. Arthritis Res Ther 2011 0.91
19 Dendritic cells maintain dermal adipose-derived stromal cells in skin fibrosis. J Clin Invest 2016 0.83
20 LTBR-pathway in Sjogren's syndrome: CXCL13 levels and B-cell-enriched ectopic lymphoid aggregates in NOD mouse lacrimal glands are dependent on LTBR. Adv Exp Med Biol 2011 0.82
21 Lymphotoxin β receptor mediates caspase-dependent tumor cell apoptosis in vitro and tumor suppression in vivo despite induction of NF-κB activation. Carcinogenesis 2013 0.80
22 Feasibility of the use of combinatorial chemokine arrays to study blood and CSF in multiple sclerosis. PLoS One 2013 0.79
23 Increased intracranial pressure is associated with elevated cerebrospinal fluid ADH levels in closed-head injury. Neurol Res 2010 0.75
24 Workshop summary: control of lymphocyte function and repertoire by the TNF superfamily. Adv Exp Med Biol 2011 0.75